Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

The aim of the present study is to investigate the synergic role of <sup>68</sup>Ga-PSMA PET/MRI and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in prostate cancer (PCa) staging. We present pilot data on twenty-two patients with biopsy-proven PCa that underwent <sup>68</sup>...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paola Mapelli, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Giorgio Brembilla, Vito Cucchiara, Naghia Ahmed, Carolina Bezzi, Luca Presotto, Valentino Bettinardi, Annarita Savi, Patrizia Magnani, Raffaele Menichini, Angela Coliva, Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Massimo Freschi, Alberto Briganti, Francesco De Cobelli, Paola Scifo, Maria Picchio
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
hybrid imaging
PET/MRI
PSMA
RM2
prostate cancer
multimodal imaging
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/4ecd835d579a4984862cb5adb3863929
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/4ecd835d579a4984862cb5adb3863929

Ejemplares similares